James Investment Research’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-60,225
Closed -$1.19M 846
2018
Q4
$1.19M Buy
60,225
+54,050
+875% +$964K 0.07% 235
2018
Q3
$109K Hold
6,175
﹤0.01% 613
2018
Q2
$133K Hold
6,175
0.01% 601
2018
Q1
$137K Sell
6,175
-68,480
-92% -$1.89M 0.01% 588
2017
Q4
$2.27M Buy
74,655
+13,155
+21% +$350K 0.08% 233
2017
Q3
$1.49M Buy
+61,500
New +$1.64M 0.05% 411

Other funds holding EXEL

James Investment Research's EXEL Position: Q1 2019 in Review

James Investment Research sold out of Exelixis (EXEL) in Q1 2019, closing a stake of 60,225 shares — an estimated $1.19M sold.

James Investment Research first reported a position in EXEL in Q3 2017 and held it in 6 quarters. The position peaked at $2.27M in Q4 2017. 378 funds tracked by Wall St. Rank hold EXEL as of Q1 2019.

  • James Investment Research reported no remaining Exelixis position as of Q1 2019 after selling out during the quarter.
  • James Investment Research sold 60,225 Exelixis shares in Q1 2019, an estimated $1.19M.
  • James Investment Research first reported a position in Exelixis in Q3 2017 and held it in 6 quarters.
  • James Investment Research's Exelixis position peaked at $2.27M in Q4 2017.
  • 378 funds tracked by Wall St. Rank held Exelixis as of Q1 2019.

Based on James Investment Research's 13F filing for Q1 2019, filed 26 Apr 2019.